Newsroom

Sneak peek at upcoming oncolytic virus trial

January 29, 2014

Dr. John Bell was interviewed in Biotechnology Focus magazine about his work in developing oncolytic viruses for the treatment of cancer, including a world-first clinical trial with a virus called Maraba. The trial, which will be led by Dr. Derek Jonker, will evaluate Maraba in combination with a novel anti-cancer vaccine. It is expected to start later this year. This project is a collaboration with CHEO, McMaster and the Ontario Institute for Cancer Research.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Jennifer Ganton
Director, Communications and Public Relations
Ottawa Hospital Research Institute
613-798-5555 x 73325
613-614-5253 (cell)
jganton@ohri.ca